Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Characterization of a Novel Mutation in the NADH-Cytochrome b5 Reductase Gene Responsible for Rare Hereditary Methaemoglobinaemia Type I

Characterization of a Novel Mutation in the NADH-Cytochrome b5 Reductase Gene Responsible for... Recessive congenital methaemoglobinaemia (RCM) is a very rare recessive genetic disorder (OMIM 250800) caused by a deficiency of NADH-cytochrome b5 reductase (cb5r). Two clinical forms of methaemoglobinaemia have been described [1]. In RCM type I, the cb5r deficiency is limited to erythrocytes, and cyanosis is the only clinical symptom. In RCM type II, cyanosis is associated with severe neurological impairment, because the cb5r deficiency is generalized to all tissues [2]. In general, mutations resulting in the synthesis of unstable cb5r lead to type I methaemoglobinaemia, while mutations associated with severe loss of enzyme activity are often linked to RCM type II. Until now, >40 mutations in unrelated patients from different populations have been described [3].Here, we report a novel CYB5R3 gene mutation leading to RCM type I, diagnosed in a Polish family. We also discuss the functional effect of the detected mutation on the structure of the enzyme.Patient E.B. has been under the care of the Oncology and Haematology Department at the University Children's Hospital of Krakow since March 2011. He was diagnosed with methaemoglobinaemia in the neonatal period. The concentration of methaemoglobin (MetHb) was 3.4-8.4% at that time, and he was given an infusion of methylene blue. During http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Haematologica Karger

Characterization of a Novel Mutation in the NADH-Cytochrome b5 Reductase Gene Responsible for Rare Hereditary Methaemoglobinaemia Type I

Loading next page...
 
/lp/karger/characterization-of-a-novel-mutation-in-the-nadh-cytochrome-b5-Phbz31uVy1

References (11)

Publisher
Karger
Copyright
© 2013 S. Karger AG, Basel
ISSN
0001-5792
eISSN
1421-9662
DOI
10.1159/000347041
Publisher site
See Article on Publisher Site

Abstract

Recessive congenital methaemoglobinaemia (RCM) is a very rare recessive genetic disorder (OMIM 250800) caused by a deficiency of NADH-cytochrome b5 reductase (cb5r). Two clinical forms of methaemoglobinaemia have been described [1]. In RCM type I, the cb5r deficiency is limited to erythrocytes, and cyanosis is the only clinical symptom. In RCM type II, cyanosis is associated with severe neurological impairment, because the cb5r deficiency is generalized to all tissues [2]. In general, mutations resulting in the synthesis of unstable cb5r lead to type I methaemoglobinaemia, while mutations associated with severe loss of enzyme activity are often linked to RCM type II. Until now, >40 mutations in unrelated patients from different populations have been described [3].Here, we report a novel CYB5R3 gene mutation leading to RCM type I, diagnosed in a Polish family. We also discuss the functional effect of the detected mutation on the structure of the enzyme.Patient E.B. has been under the care of the Oncology and Haematology Department at the University Children's Hospital of Krakow since March 2011. He was diagnosed with methaemoglobinaemia in the neonatal period. The concentration of methaemoglobin (MetHb) was 3.4-8.4% at that time, and he was given an infusion of methylene blue. During

Journal

Acta HaematologicaKarger

Published: Jan 1, 2013

There are no references for this article.